. . . . . . . . . . . . . . . . . "Policondritis recidivante"@es . . . . "10248"^^ . . "2684401"^^ . "Polychondritis recidivans (Oudgrieks: \u03C0\u03BF\u03BB\u03CD\u03C2 polus, veel; \u03C7\u03CC\u03BD\u03B4\u03C1\u03BF\u03C2 chondros, kraakbeen; -\u03B9\u03C4\u03B9\u03C2 -itis, ontsteking) is een zeer zeldzame ziekte (ca. 55 mensen per jaar in Nederland) aan het kraakbeen dat gekenmerkt wordt door herhaalde episodes van ontsteking aan voornamelijk de oren, neus, het strottehoofd en de kraakbeenringen van de luchtpijp en hoofdbronchie\u00EBn. De ontstekingen worden soms gevolgd door degeneratie en misvorming van het kraakbeen, wat bij de betrokkenheid van de luchtwegen en/of hartkleppen tot levensbedreigende complicaties kan leiden. Het immuunsysteem is verantwoordelijk voor de ontstekingsreactie van het kraakbeen. Polychondritis recidivans wordt beschouwd als een auto-immuunziekte en wordt meestal behandeld door het geneeskundige specialisme van de reumatologie."@nl . . "Per policondrite ricorrente in campo medico, si intende una rara forma di infiammazione e distruzione della cartilagine a carattere episodico."@it . . . . . "Polykondrit"@sv . . . . . . . . . . . . . "D011081"@en . . . "\u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u063A\u0636\u0627\u0631\u064A\u0641 \u0627\u0644\u0646\u0627\u0643\u0633 (\u064A\u064F\u0639\u0631\u0641 \u0623\u064A\u0636\u064B\u0627 \u0628\u0627\u0633\u0645 \u00AB\u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u063A\u0636\u0627\u0631\u064A\u0641 \u0627\u0644\u0636\u0645\u0648\u0631\u064A\u060C\u00BB \u0648\u00AB\u0627\u0644\u062A\u0644\u064A\u0646 \u0627\u0644\u063A\u0636\u0631\u0648\u0641\u064A \u0627\u0644\u0645\u062C\u0645\u0648\u0639\u064A\u00BB) \u0647\u0648 \u062D\u0627\u0644\u0629 \u062A\u0644\u0641 \u0627\u0644\u063A\u0636\u0631\u0648\u0641. \u0648\u062A\u064F\u0639\u0631\u0641 \u0647\u0630\u0647 \u0627\u0644\u062D\u0627\u0644\u0629 \u0623\u064A\u0636\u064B\u0627 \u0628\u0627\u0633\u0645 \u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u063A\u0636\u0627\u0631\u064A\u0641 \u0627\u0644\u0636\u0645\u0648\u0631\u064A \u0627\u0644\u0645\u0632\u0645\u0646 \u0648\u0645\u062A\u0644\u0627\u0632\u0645\u0629 \u0645\u064A\u0646\u0628\u064A\u0631\u063A-\u0623\u0644\u062B\u064A\u0631-\u064A\u0648\u0647\u0644\u064A\u0646\u063A\u0631\u060C \u0648\u0645\u0631\u0636 \u0641\u0648\u0646 \u0645\u064A\u0646\u0628\u064A\u0631\u063A \u0648\u062A\u0644\u064A\u064F\u0646 \u0627\u0644\u063A\u0636\u0631\u0648\u0641 \u0627\u0644\u0645\u0639\u0645\u0645 \u0648\u062A\u0644\u064A\u064F\u0641 \u0627\u0644\u063A\u0636\u0631\u0648\u0641\u064A \u0627\u0644\u062C\u0645\u0648\u0639\u064A."@ar . . . . . . . . . . . . . "M94.1" . . . "Per policondrite ricorrente in campo medico, si intende una rara forma di infiammazione e distruzione della cartilagine a carattere episodico."@it . "2000"@en . . . . . . . . . . . . "Relapsing polychondritis is a multi-systemic condition characterized by repeated episodes of inflammation and deterioration of cartilage. The often painful disease can cause joint deformity and be life-threatening if the respiratory tract, heart valves, or blood vessels are affected. The exact mechanism is poorly understood, but it is thought to be related to an immune-mediated attack on particular proteins that are abundant in cartilage. The diagnosis is reached on the basis of the symptoms and supported by investigations such as blood tests and sometimes other investigations. Treatment may involve symptomatic treatment with painkillers or anti-inflammatory medications, and more severe cases may require suppression of the immune system."@en . . . . "\u518D\u767A\u6027\u591A\u767A\u8EDF\u9AA8\u708E\uFF08\u3055\u3044\u306F\u3064\u305B\u3044\u305F\u306F\u3064\u306A\u3093\u3053\u3064\u3048\u3093\u3001\u518D\u767A\u6027\u591A\u767A\u6027\u8EDF\u9AA8\u708E\u3068\u3082\u3001\u82F1: relapsing polychondritis: RP\uFF09\u306F\u3001\u539F\u56E0\u4E0D\u660E\u306E\u8EDF\u9AA8\u306E\u7834\u58CA\u30FB\u816B\u8139\u3092\u6765\u305F\u3059\u6162\u6027\u75BE\u60A3\u3067\u3042\u308B\u3002\u81A0\u539F\u75C5\u985E\u7E01\u75BE\u60A3\u3001\u81EA\u5DF1\u514D\u75AB\u75BE\u60A3\u306E\u3072\u3068\u3064\u3067\u3001\u5168\u8EAB\u306E\u8EDF\u9AA8\u306B\u708E\u75C7\u3092\u304D\u305F\u3057\u3001\u305D\u306E\u540D\u306E\u3068\u304A\u308A\u5BDB\u89E3\u3068\u518D\u767A\u3092\u7E70\u308A\u8FD4\u3059\u30021923\u5E74 Jaksc-Wartenhorst\u304C\u75C7\u4F8B\u5831\u544A\u3057\u30011960\u5E74 Pearson\u3089\u304C\u73FE\u5728\u306E\u75C5\u540D\u3067\u81EA\u9A13\u4F8B\u3092New England Journal of Medicine\u306B\u5831\u544A\u3057\u305F\u3002 \u65E5\u672C\u3067\u306E\u6B63\u78BA\u306A\u7D71\u8A08\u306F\u306A\u3044\u304C\u3001\u30A2\u30E1\u30EA\u30AB\u30FB\u30DF\u30CD\u30BD\u30BF\u5DDE\u30ED\u30C1\u30A7\u30B9\u30BF\u30FC\u3067\u306F\u5E74\u9593100\u4E07\u4EBA\u5F53\u305F\u308A3.5\u4EBA\u304C\u767A\u75C7\u3059\u308B\u3068\u3044\u3046\u3002\u521D\u767A\u75C7\u72B6\u306F\u8033\u4ECB\u306E\u75DB\u307F\u3084\u306F\u308A\u611F\u3067\u3042\u308B\u3053\u3068\u304C\u591A\u3044\u304C\u3001\u75C7\u72B6\u3084\u75C5\u5909\u90E8\u4F4D\u306F\u60A3\u8005\u306B\u3088\u3063\u3066\u591A\u5F69\u3067\u3042\u308B\u3002\u305D\u306E\u307B\u304B\u95A2\u7BC0\u3001\u3001\u76EE\u3001\u9F3B\u3001\u76AE\u819A\u306A\u3069\u306B\u50B7\u5BB3\u304C\u767A\u75C7\u3059\u308B\u3002\u6709\u7528\u306A\u691C\u67FB\u306F\u3042\u307E\u308A\u306A\u304F\u3001\u8A3A\u65AD\u306F\u81E8\u5E8A\u7684\u306B\u306A\u3055\u308C\u308B\u304C\u3001\u75C5\u5909\u90E8\u4F4D\u306E\u75C5\u7406\u5B66\u7684\u6240\u898B\u306F\u6709\u7528\u3067\u3042\u308B\u3002\u8EDF\u9AA8\u306E\u5909\u6027\uFF08\u597D\u5869\u57FA\u6027\u4F4E\u4E0B\u3001lacunae\u306E\u6D88\u5931\u3001\u7DDA\u7DAD\u5316\uFF09\u304A\u3088\u3073\u708E\u75C7\u7D30\u80DE\u6D78\u6F64\u304C\u898B\u3089\u308C\u308B\u3002\u6CBB\u7642\u306B\u306F\u30B9\u30C6\u30ED\u30A4\u30C9\u3084\u514D\u75AB\u6291\u5236\u5264\u3092\u7528\u3044\u308B\u3002\u5BDB\u89E3\u3068\u518D\u767A\u3092\u7E70\u308A\u8FD4\u3059\u3082\u306E\u306E\u3001\u5FC3\u75C5\u5909\u304C\u306A\u3051\u308C\u3070\u3001\u6B7B\u4EA1\u306E\u539F\u56E0\u3068\u306F\u3042\u307E\u308A\u306A\u3089\u306A\u3044\u3002"@ja . . . . . "M94.1"@en . . . "La polychondrite atrophiante, aussi d\u00E9sign\u00E9e polychondrite chronique atrophiante ou polychondrite r\u00E9cidivante, est une connectivite rare, caract\u00E9ris\u00E9e par l'inflammation r\u00E9cidivante des cartilages (tels nez, oreilles, larynx, trach\u00E9e) et \u00E9voluant par pouss\u00E9es entrecoup\u00E9es d'accalmies. Elle survient habituellement chez l'adulte d'\u00E2ge moyen, mais peut survenir \u00E0 tout \u00E2ge (des formes p\u00E9diatriques sont rapport\u00E9es). La pr\u00E9dominance f\u00E9minine est peu marqu\u00E9e."@fr . . "\u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u063A\u0636\u0627\u0631\u064A\u0641 \u0627\u0644\u0646\u0627\u0643\u0633"@ar . . "Relapsing polychondritis"@en . "Ear inflammation with sparing of ear lobe in a person with relapsing polychondritis"@en . "Polychondritis recidivans"@nl . . . . . . . "La policondritis recidivante es una enfermedad inflamatoria sist\u00E9mica de etiolog\u00EDa desconocida, caracterizada por la presencia de lesiones recurrentes en las estructuras cartilaginosas, \u00F3rganos de los sentidos y sistema cardiovascular.\u200B Principalmente afecta al pabell\u00F3n auricular, tabique nasal, laringe, tr\u00E1quea y articulaciones.\u200B En ocasiones se puede relacionar con otras enfermedades autoinmunes sist\u00E9micas. Es una enfermedad poco frecuente. Afecta predominantemente a la raza cauc\u00E1sica en la 3\u00AA y 6\u00AA d\u00E9cadas de la vida."@es . . . . . "30574"^^ . . . . . . . . . . . . "Polykondrit \u00E4r en autoimmun sjukdom som drabbar brosk i kroppen. N\u00E4sa, \u00F6ra, revben samt hj\u00E4rtklaffar kan vara drabbade d\u00E5 brosket svullnar. Tr\u00F6tthet och feber \u00E4r vanligt. Kortisol och cellgifter \u00E4r den vanliga behandlingen. Denna artikel om immunologi, smitt\u00E4mnen eller epidemier saknar v\u00E4sentlig information. Du kan hj\u00E4lpa till genom att l\u00E4gga till den."@sv . . . . . . . . . . "733.99"^^ . . . . "La policondritis recidivant \u00E9s una afecci\u00F3 multisist\u00E8mica caracteritzada per episodis repetits d'inflamaci\u00F3 i deteriorament del cart\u00EDlag. La malaltia, sovint dolorosa, pot causar deformitats articulars i posar en perill la vida si es veuen afectades les vies respirat\u00F2ries, les v\u00E0lvules card\u00EDaques o els vasos sanguinis. El mecanisme exacte no s'ent\u00E9n del tot, per\u00F2 es creu que est\u00E0 relacionat amb un atac immunitari a prote\u00EFnes particulars del cart\u00EDlag."@ca . . . . "Policondrite recidivante"@pt . "\u518D\u767A\u6027\u591A\u767A\u8EDF\u9AA8\u708E\uFF08\u3055\u3044\u306F\u3064\u305B\u3044\u305F\u306F\u3064\u306A\u3093\u3053\u3064\u3048\u3093\u3001\u518D\u767A\u6027\u591A\u767A\u6027\u8EDF\u9AA8\u708E\u3068\u3082\u3001\u82F1: relapsing polychondritis: RP\uFF09\u306F\u3001\u539F\u56E0\u4E0D\u660E\u306E\u8EDF\u9AA8\u306E\u7834\u58CA\u30FB\u816B\u8139\u3092\u6765\u305F\u3059\u6162\u6027\u75BE\u60A3\u3067\u3042\u308B\u3002\u81A0\u539F\u75C5\u985E\u7E01\u75BE\u60A3\u3001\u81EA\u5DF1\u514D\u75AB\u75BE\u60A3\u306E\u3072\u3068\u3064\u3067\u3001\u5168\u8EAB\u306E\u8EDF\u9AA8\u306B\u708E\u75C7\u3092\u304D\u305F\u3057\u3001\u305D\u306E\u540D\u306E\u3068\u304A\u308A\u5BDB\u89E3\u3068\u518D\u767A\u3092\u7E70\u308A\u8FD4\u3059\u30021923\u5E74 Jaksc-Wartenhorst\u304C\u75C7\u4F8B\u5831\u544A\u3057\u30011960\u5E74 Pearson\u3089\u304C\u73FE\u5728\u306E\u75C5\u540D\u3067\u81EA\u9A13\u4F8B\u3092New England Journal of Medicine\u306B\u5831\u544A\u3057\u305F\u3002 \u65E5\u672C\u3067\u306E\u6B63\u78BA\u306A\u7D71\u8A08\u306F\u306A\u3044\u304C\u3001\u30A2\u30E1\u30EA\u30AB\u30FB\u30DF\u30CD\u30BD\u30BF\u5DDE\u30ED\u30C1\u30A7\u30B9\u30BF\u30FC\u3067\u306F\u5E74\u9593100\u4E07\u4EBA\u5F53\u305F\u308A3.5\u4EBA\u304C\u767A\u75C7\u3059\u308B\u3068\u3044\u3046\u3002\u521D\u767A\u75C7\u72B6\u306F\u8033\u4ECB\u306E\u75DB\u307F\u3084\u306F\u308A\u611F\u3067\u3042\u308B\u3053\u3068\u304C\u591A\u3044\u304C\u3001\u75C7\u72B6\u3084\u75C5\u5909\u90E8\u4F4D\u306F\u60A3\u8005\u306B\u3088\u3063\u3066\u591A\u5F69\u3067\u3042\u308B\u3002\u305D\u306E\u307B\u304B\u95A2\u7BC0\u3001\u3001\u76EE\u3001\u9F3B\u3001\u76AE\u819A\u306A\u3069\u306B\u50B7\u5BB3\u304C\u767A\u75C7\u3059\u308B\u3002\u6709\u7528\u306A\u691C\u67FB\u306F\u3042\u307E\u308A\u306A\u304F\u3001\u8A3A\u65AD\u306F\u81E8\u5E8A\u7684\u306B\u306A\u3055\u308C\u308B\u304C\u3001\u75C5\u5909\u90E8\u4F4D\u306E\u75C5\u7406\u5B66\u7684\u6240\u898B\u306F\u6709\u7528\u3067\u3042\u308B\u3002\u8EDF\u9AA8\u306E\u5909\u6027\uFF08\u597D\u5869\u57FA\u6027\u4F4E\u4E0B\u3001lacunae\u306E\u6D88\u5931\u3001\u7DDA\u7DAD\u5316\uFF09\u304A\u3088\u3073\u708E\u75C7\u7D30\u80DE\u6D78\u6F64\u304C\u898B\u3089\u308C\u308B\u3002\u6CBB\u7642\u306B\u306F\u30B9\u30C6\u30ED\u30A4\u30C9\u3084\u514D\u75AB\u6291\u5236\u5264\u3092\u7528\u3044\u308B\u3002\u5BDB\u89E3\u3068\u518D\u767A\u3092\u7E70\u308A\u8FD4\u3059\u3082\u306E\u306E\u3001\u5FC3\u75C5\u5909\u304C\u306A\u3051\u308C\u3070\u3001\u6B7B\u4EA1\u306E\u539F\u56E0\u3068\u306F\u3042\u307E\u308A\u306A\u3089\u306A\u3044\u3002"@ja . . . . "2000"^^ . . . "med"@en . "Polychondritis"@de . . . . . . . . . . . . . . . . . . . . . . "Policondritis recidivant"@ca . . . . . "med"@en . . . . . . . . . . "10248" . . . ""@en . . . . "Policondrite ricorrente"@it . . . . . . . . . "Atrophic polychondritis, systemic chondromalacia, chronic atrophic polychondritis, Meyenburg-Altherr-Uehlinger syndrome, generalized chondromalacia"@en . "Relapsing polychondritis"@en . . "La policondritis recidivant \u00E9s una afecci\u00F3 multisist\u00E8mica caracteritzada per episodis repetits d'inflamaci\u00F3 i deteriorament del cart\u00EDlag. La malaltia, sovint dolorosa, pot causar deformitats articulars i posar en perill la vida si es veuen afectades les vies respirat\u00F2ries, les v\u00E0lvules card\u00EDaques o els vasos sanguinis. El mecanisme exacte no s'ent\u00E9n del tot, per\u00F2 es creu que est\u00E0 relacionat amb un atac immunitari a prote\u00EFnes particulars del cart\u00EDlag. El diagn\u00F2stic s'arriba sobre la base dels signes i s\u00EDmptomes i es recolza en investigacions com ara an\u00E0lisis de sang i, de vegades, altres investigacions. El tractament pot implicar tractament simptom\u00E0tic amb analg\u00E8sics o antiinflamatoris, i els casos m\u00E9s greus poden requerir la supressi\u00F3 del sistema immunitari.."@ca . . "Polykondrit \u00E4r en autoimmun sjukdom som drabbar brosk i kroppen. N\u00E4sa, \u00F6ra, revben samt hj\u00E4rtklaffar kan vara drabbade d\u00E5 brosket svullnar. Tr\u00F6tthet och feber \u00E4r vanligt. Kortisol och cellgifter \u00E4r den vanliga behandlingen. Denna artikel om immunologi, smitt\u00E4mnen eller epidemier saknar v\u00E4sentlig information. Du kan hj\u00E4lpa till genom att l\u00E4gga till den."@sv . . . . "Die rezidivierende Polychondritis, auch Relapsing Polychondritis, Panchondritis, systematisierte Chondromalazie oder Polychondritis atrophicans genannt, ist eine sehr seltene Knorpelkrankheit rheumatischer und immunologischer Natur. Kennzeichnend f\u00FCr die Polychondritis sind chronisch wiederkehrende (rezidivierende) Knorpelentz\u00FCndungen, durch die das Knorpelgewebe seine Festigkeit verliert, was zu Deformationen oder Versagen der Organfunktion f\u00FChren kann. Das Krankheitsbild wurde 1923 von dem \u00F6sterreichischen Internisten Rudolf von Jaksch beschrieben und wird auch als Meyenburg-Altherr-Uehlinger-Syndrom bezeichnet."@de . . "D011081" . . . "1106092929"^^ . "Policondrite recidivante (tamb\u00E9m conhecido como \"policondrite atr\u00F3fica\", e \"condromalacia sist\u00EAmica\") \u00E9 uma condi\u00E7\u00E3o multissist\u00EAmica caracterizada pela inflama\u00E7\u00E3o e degrada\u00E7\u00E3o da cartilagem. A doen\u00E7a \u00E9 muitas vezes dolorosa e pode causar deformidade e possuir risco de vida quando o trato respirat\u00F3rio, v\u00E1lvulas card\u00EDacas ou vasos sangu\u00EDneos s\u00E3o afetados. A doen\u00E7a n\u00E3o \u00E9 bem conhecida, n\u00E3o \u00E9 bem compreendida, e \u00E9 muitas vezes n\u00E3o diagnostic\u00E1vel."@pt . . . . "La policondritis recidivante es una enfermedad inflamatoria sist\u00E9mica de etiolog\u00EDa desconocida, caracterizada por la presencia de lesiones recurrentes en las estructuras cartilaginosas, \u00F3rganos de los sentidos y sistema cardiovascular.\u200B Principalmente afecta al pabell\u00F3n auricular, tabique nasal, laringe, tr\u00E1quea y articulaciones.\u200B En ocasiones se puede relacionar con otras enfermedades autoinmunes sist\u00E9micas. Es una enfermedad poco frecuente. Afecta predominantemente a la raza cauc\u00E1sica en la 3\u00AA y 6\u00AA d\u00E9cadas de la vida."@es . . . . "733.99" . . . . . . "Relapsing polychondritis"@en . . . . . . . . . "\u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u063A\u0636\u0627\u0631\u064A\u0641 \u0627\u0644\u0646\u0627\u0643\u0633 (\u064A\u064F\u0639\u0631\u0641 \u0623\u064A\u0636\u064B\u0627 \u0628\u0627\u0633\u0645 \u00AB\u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u063A\u0636\u0627\u0631\u064A\u0641 \u0627\u0644\u0636\u0645\u0648\u0631\u064A\u060C\u00BB \u0648\u00AB\u0627\u0644\u062A\u0644\u064A\u0646 \u0627\u0644\u063A\u0636\u0631\u0648\u0641\u064A \u0627\u0644\u0645\u062C\u0645\u0648\u0639\u064A\u00BB) \u0647\u0648 \u062D\u0627\u0644\u0629 \u062A\u0644\u0641 \u0627\u0644\u063A\u0636\u0631\u0648\u0641. \u0648\u062A\u064F\u0639\u0631\u0641 \u0647\u0630\u0647 \u0627\u0644\u062D\u0627\u0644\u0629 \u0623\u064A\u0636\u064B\u0627 \u0628\u0627\u0633\u0645 \u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u063A\u0636\u0627\u0631\u064A\u0641 \u0627\u0644\u0636\u0645\u0648\u0631\u064A \u0627\u0644\u0645\u0632\u0645\u0646 \u0648\u0645\u062A\u0644\u0627\u0632\u0645\u0629 \u0645\u064A\u0646\u0628\u064A\u0631\u063A-\u0623\u0644\u062B\u064A\u0631-\u064A\u0648\u0647\u0644\u064A\u0646\u063A\u0631\u060C \u0648\u0645\u0631\u0636 \u0641\u0648\u0646 \u0645\u064A\u0646\u0628\u064A\u0631\u063A \u0648\u062A\u0644\u064A\u064F\u0646 \u0627\u0644\u063A\u0636\u0631\u0648\u0641 \u0627\u0644\u0645\u0639\u0645\u0645 \u0648\u062A\u0644\u064A\u064F\u0641 \u0627\u0644\u063A\u0636\u0631\u0648\u0641\u064A \u0627\u0644\u062C\u0645\u0648\u0639\u064A."@ar . . "Relapsing polychondritis is a multi-systemic condition characterized by repeated episodes of inflammation and deterioration of cartilage. The often painful disease can cause joint deformity and be life-threatening if the respiratory tract, heart valves, or blood vessels are affected. The exact mechanism is poorly understood, but it is thought to be related to an immune-mediated attack on particular proteins that are abundant in cartilage."@en . "Polychondrite atrophiante"@fr . . "Die rezidivierende Polychondritis, auch Relapsing Polychondritis, Panchondritis, systematisierte Chondromalazie oder Polychondritis atrophicans genannt, ist eine sehr seltene Knorpelkrankheit rheumatischer und immunologischer Natur. Kennzeichnend f\u00FCr die Polychondritis sind chronisch wiederkehrende (rezidivierende) Knorpelentz\u00FCndungen, durch die das Knorpelgewebe seine Festigkeit verliert, was zu Deformationen oder Versagen der Organfunktion f\u00FChren kann. Das Krankheitsbild wurde 1923 von dem \u00F6sterreichischen Internisten Rudolf von Jaksch beschrieben und wird auch als Meyenburg-Altherr-Uehlinger-Syndrom bezeichnet."@de . . . "Polychondritis recidivans (Oudgrieks: \u03C0\u03BF\u03BB\u03CD\u03C2 polus, veel; \u03C7\u03CC\u03BD\u03B4\u03C1\u03BF\u03C2 chondros, kraakbeen; -\u03B9\u03C4\u03B9\u03C2 -itis, ontsteking) is een zeer zeldzame ziekte (ca. 55 mensen per jaar in Nederland) aan het kraakbeen dat gekenmerkt wordt door herhaalde episodes van ontsteking aan voornamelijk de oren, neus, het strottehoofd en de kraakbeenringen van de luchtpijp en hoofdbronchie\u00EBn. De ontstekingen worden soms gevolgd door degeneratie en misvorming van het kraakbeen, wat bij de betrokkenheid van de luchtwegen en/of hartkleppen tot levensbedreigende complicaties kan leiden. Het immuunsysteem is verantwoordelijk voor de ontstekingsreactie van het kraakbeen. Polychondritis recidivans wordt beschouwd als een auto-immuunziekte en wordt meestal behandeld door het geneeskundige specialisme van de reumatologie."@nl . . . . "Policondrite recidivante (tamb\u00E9m conhecido como \"policondrite atr\u00F3fica\", e \"condromalacia sist\u00EAmica\") \u00E9 uma condi\u00E7\u00E3o multissist\u00EAmica caracterizada pela inflama\u00E7\u00E3o e degrada\u00E7\u00E3o da cartilagem. A doen\u00E7a \u00E9 muitas vezes dolorosa e pode causar deformidade e possuir risco de vida quando o trato respirat\u00F3rio, v\u00E1lvulas card\u00EDacas ou vasos sangu\u00EDneos s\u00E3o afetados. A doen\u00E7a n\u00E3o \u00E9 bem conhecida, n\u00E3o \u00E9 bem compreendida, e \u00E9 muitas vezes n\u00E3o diagnostic\u00E1vel. Tamb\u00E9m \u00E9 conhecido como policondrite atr\u00F3fica cr\u00F4nica, s\u00EDndrome de Meyenburg-Altherr-Uehlinger, doen\u00E7a de von Meyenburg, condromalacia generalizada, e condromalacia sist\u00EAmica."@pt . "La polychondrite atrophiante, aussi d\u00E9sign\u00E9e polychondrite chronique atrophiante ou polychondrite r\u00E9cidivante, est une connectivite rare, caract\u00E9ris\u00E9e par l'inflammation r\u00E9cidivante des cartilages (tels nez, oreilles, larynx, trach\u00E9e) et \u00E9voluant par pouss\u00E9es entrecoup\u00E9es d'accalmies. Elle survient habituellement chez l'adulte d'\u00E2ge moyen, mais peut survenir \u00E0 tout \u00E2ge (des formes p\u00E9diatriques sont rapport\u00E9es). La pr\u00E9dominance f\u00E9minine est peu marqu\u00E9e."@fr . . . . . . "\u518D\u767A\u6027\u591A\u767A\u8EDF\u9AA8\u708E"@ja . . .